Alpha 2.0
Login Register
» Authors » J A Puig-Butille

J A Puig-Butille

Explore the profile of J A Puig-Butille including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 17
Citations 153
Followers 0
Related Specialties
Dermatology
Infectious Diseases
Oncology
Top 10 Co-Authors
S Puig
J Malvehy
C Badenas
C Carrera
P Aguilera
M Potrony
G Tell-Marti
L Alos
E Bagatin
F C Pozzobon
Published In
Br J Dermatol
J Eur Acad Dermatol Venereol
Eur J Nucl Med Mol Imaging
Clin Exp Dermatol
ESMO Open
Affiliations
Soon will be listed here.
Recent Articles
1.
Analytical validation of HER2DX genomic test for early-stage HER2-positive breast cancer
Marin-Aguilera M, Jares P, Sanfeliu E, Villacampa G, Hernandez-Lllan E, Martinez-Puchol A, et al.
ESMO Open . 2024 Mar; 9(3):102903. PMID: 38452436
Background: HER2DX, a multianalyte genomic test, has been clinically validated to predict breast cancer recurrence risk (relapse risk score), the probability of achieving pathological complete response post-neoadjuvant therapy (pCR likelihood...
2.
Synchronous primary cutaneous melanomas: a descriptive study of their clinical features, histology, genetic background of the patients and clinical outcomes
Antunez-Lay A, Podlipnik S, Carrera C, Potrony M, Tell-Marti G, Badenas C, et al.
J Eur Acad Dermatol Venereol . 2022 Jul; 36(12):2364-2372. PMID: 35882522
Background: Around 0.5% of cutaneous melanoma (CM) patients will present with synchronous melanomas when first seen. Moreover, 26-40% of patients with multiple primary melanomas present with synchronous lesions. Objectives: To...
3.
Cell-free DNA concentration and fragment size fraction correlate with FDG PET/CT-derived parameters in NSCLC patients
Gonzalez de Aledo-Castillo J, Casanueva-Eliceiry S, Soler-Perromat A, Fuster D, Pastor V, Reguart N, et al.
Eur J Nucl Med Mol Imaging . 2021 Apr; 48(11):3631-3642. PMID: 33797597
Purpose: The aim of our study was to investigate the correlation between cfDNA concentration and fragment size fraction with FDG PET/CT- and CT-derived parameters in untreated NSCLC patient. Methods: Fifty-three...
4.
Detection of cell-free circulating BRAF by droplet digital polymerase chain reaction in patients with and without melanoma under dermatological surveillance
Calbet-Llopart N, Potrony M, Tell-Marti G, Carrera C, Barreiro A, Aguilera P, et al.
Br J Dermatol . 2019 May; 182(2):382-389. PMID: 31102256
Background: The p.V600E mutation in the BRAF protein is the most frequent mutation in cutaneous melanoma and is a recurrent alteration found in common benign naevi. Analysis of the cell-free...
5.
Fibroblast activation and abnormal extracellular matrix remodelling as common hallmarks in three cancer-prone genodermatoses
Chacon-Solano E, Leon C, Diaz F, Garcia-Garcia F, Garcia M, Escamez M, et al.
Br J Dermatol . 2019 Jan; 181(3):512-522. PMID: 30693469
Background: Recessive dystrophic epidermolysis bullosa (RDEB), Kindler syndrome (KS) and xeroderma pigmentosum complementation group C (XPC) are three cancer-prone genodermatoses whose causal genetic mutations cannot fully explain, on their own,...
6.
POT1 germline mutations but not TERT promoter mutations are implicated in melanoma susceptibility in a large cohort of Spanish melanoma families
Potrony M, Puig-Butille J, Ribera-Sola M, Iyer V, Robles-Espinoza C, Aguilera P, et al.
Br J Dermatol . 2018 Nov; 181(1):105-113. PMID: 30451293
Background: Germline mutations in telomere-related genes such as POT1 and TERT predispose individuals to familial melanoma. Objectives: To evaluate the prevalence of germline mutations in POT1 and TERT in a...
7.
Association between dermoscopic and reflectance confocal microscopy features of cutaneous melanoma with BRAF mutational status
Bombonato C, Ribero S, Pozzobon F, Puig-Butille J, Badenas C, Carrera C, et al.
J Eur Acad Dermatol Venereol . 2016 Oct; 31(4):643-649. PMID: 27790766
Background: Melanomas harbouring common genetic mutations might share certain morphological features detectable with dermoscopy and reflectance confocal microscopy. BRAF mutational status is crucial for the management of metastatic melanoma. Objectives:...
8.
Genetic susceptibility to cutaneous melanoma in southern Switzerland: role of CDKN2A, MC1R and MITF
Mangas C, Potrony M, Mainetti C, Bianchi E, Carrozza Merlani P, Mancarella Eberhardt A, et al.
Br J Dermatol . 2016 Jul; 175(5):1030-1037. PMID: 27473757
Background: Nearly 10% of all cases of cutaneous melanoma (CM) occur in patients with a personal or family history of the disease. Objectives: To obtain information about genetic predisposition to...
9.
Discrepant mutational status between naevi and melanomas in naevus-associated melanomas: about mutation-specific immunohistochemistry: reply from the authors
Shitara D, Tell-Marti G, Badenas C, Enokihara M, Alos L, Larque A, et al.
Br J Dermatol . 2016 Jun; 175(2):435. PMID: 27310877
No abstract available.
10.
Mutational status of naevus-associated melanomas
Shitara D, Tell-Marti G, Badenas C, Enokihara M, Alos L, Larque A, et al.
Br J Dermatol . 2015 Apr; 173(3):671-80. PMID: 25857817
Background: The origin of melanoma has always been a debated subject, as well as the role of adjacent melanocytic naevi. Epidemiological and histopathological studies point to melanomas arising either de...